France· FR:69568222
RIMIFON 150 mg, comprimé
A isoniazid product containing isoniazide, registered in France by PHARMHOLDING (LUXEMBOURG), on the national reimbursement list. The same ATC class is registered in 15 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Isoniazid is registered in 15 of 19 countries.
Countries holding a registration under ATC J04AC01 (isoniazid), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 9 of them publish a price we can compare per daily dose
Isoniazid · ATC J04AC01
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of isoniazid costs, country by country.
Normalised to the WHO defined daily dose (0.3 g), the median price runs from $1.15 in France to $4.87 in Switzerland — a ×4.3 gap.
- France: $1.15 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Isoniazid · price per daily dose (0.3 g)
USD · FX 28 Sept 2026
- CH Switzerland$4.87
- FR France$1.15
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- ISONIAZIDE
- Manufacturer
- PHARMHOLDING (LUXEMBOURG)
- Country
- France (FR)
- ATC code
- J04AC01
- ATC class
- Isoniazid
- Defined daily dose
- 0.3 g, O
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009347797871 tube(s) polypropylène de 100 comprimé(s)EUR 44.03
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
335 interactions on record for isoniazid.
Graded by severity as the source publishes them — 5 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Isoniazid · interactions on record
335 records
- 5 severe
- 233 moderate
- 26 minor
- 67 info
Most severe, free to view
- AlosetronA03AE01moderate
- Sodium picosulfateA06AB08moderate
- BudesonideA07EA06moderate
- LiraglutidA08AX02moderate
4 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Isoniazid in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomCemidon Intravenoso 300mg/5ml solution for injection ampoulesImported (Spain)
- United StatesisoniazidMarlex Pharmaceuticals, Inc.
- NorwayIsoniazid SASykehusapotekene HF
- Japanイソニアジド
- CanadaPDP-ISONIAZIDPENDOPHARM DIVISION OF PHARMASCIENCE INC
- GermanyIsozidEsteve Pharmaceuticals Gmbh
- CzechiaISONIAZID
- ItalyNICOZID*5 fiale IM EV 500 mg 5 mlPIAM FARMACEUTICI SpA
Authorised across Europe · EMA
The same active substance is authorised in 20 EEA countries. Names it is sold under:
- Austria · Inh Agepha
- Belgium · Nicotibine
- Bulgaria · Изонид, Изонид Дансон-Бг
- Czechia · Nidrazid
- Germany · Isozid, Isozid N
- Denmark · Isoniazid Oba
- Spain · Cemidon
- Finland · Tubilysin
- United Kingdom (Northern Ireland) · Isoniazid Dawa, Isoniazid Macleods Pharma Uk
- Greece · Dianicotyl
- Hungary · Isonicid
- Iceland · Tibinide
- Italy · Nicozid
- Luxembourg · Nicotibine
- Netherlands · Isoniazide Costero
- Poland · Nidrazid
- Portugal · Isoniazida Labesfal
- Romania · Izoniazidă Arena, Izoniazida Atb
- Sweden · Tibinide
- Slovakia · Nidrazid
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ca44effc-16a9-4b27-a1c7-db1cbe5f6508 GET /v1/drugs/ca44effc-16a9-4b27-a1c7-db1cbe5f6508?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "69568222",
"date_amm": "2016-11-29",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "ISONIAZIDE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about isoniazid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.